rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Juan C. Jaen

President

Company insider

Files Form 4 as: President, Arcus Biosciences; SVP, Drug Discovery & CSO, ChemoCentryx.

Every Form 4 they filed

In numbers

Trades disclosed
214
Buys
8
Sells
62
Bought
$1.4M
Sold
$15.7M
Companies
2
Companies where not an officer
0
First trade
27 Feb 2012
Last trade
10 Jul 2026
Last filed
13 Jul 2026

Companies traded

Where they are an officer
RCUS Arcus BiosciencesDirector, Officer · Biotechnology · last 10 Jul 20268 buys · 24 sells
ChemoCentryxOfficer · last 23 Jul 20130 buys · 38 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Jul 2026filed 13 Jul 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$566K19,799 at $28.61filing
10 Jul 2026filed 13 Jul 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$7,878268 at $29.40filing
10 Jul 2026filed 13 Jul 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$566K19,799 at $28.61filing
10 Jul 2026filed 13 Jul 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$7,879268 at $29.40filing
9 Jul 2026filed 13 Jul 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$1.5M48,502 at $30.05filing
9 Jul 2026filed 13 Jul 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$1.5M48,502 at $30.05filing
24 Jun 2026filed 24 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$191K6,431 at $29.66filing
24 Jun 2026filed 24 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$191K6,431 at $29.66filing
23 Jun 2026filed 24 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$389K14,067 at $27.69filing
23 Jun 2026filed 24 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$48K1,697 at $28.06filing
23 Jun 2026filed 24 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$390K14,067 at $27.69filing
23 Jun 2026filed 24 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$48K1,697 at $28.06filing
22 Jun 2026filed 24 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$250K9,236 at $27.03filing
22 Jun 2026filed 24 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$250K9,236 at $27.03filing
23 Jan 2026filed 26 Jan 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—31,000 at $0.00filing
23 Jan 2026filed 26 Jan 2026RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—126,000 at $0.00filing
23 Jan 2026filed 26 Jan 2026RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—126,000 at $0.00filing
23 Jan 2026filed 26 Jan 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—31,000 at $0.00filing
5 Jan 2026filed 7 Jan 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$633K29,670 at $21.34filing
5 Jan 2026filed 7 Jan 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Sold$46K2,053 at $22.34filing

Sectors

Health Care32
Not placed38

Buys in green, sells in red, by the company’s sector.

Related people

Alexander AzoyChief Accounting Officer · Chief Accounting Officer at Arcus Biosciences, filing Form 4 there in the last year
Carolyn C. TangGeneral Counsel · General Counsel at Arcus Biosciences, filing Form 4 there in the last year
Kathryn E. FalbergDirector · Director at Arcus Biosciences, filing Form 4 there in the last year
Yasunori KanekoDirector · Director at Arcus Biosciences, filing Form 4 there in the last year
Patrick MachadoDirector · Director at Arcus Biosciences, filing Form 4 there in the last year
Donald J. TrumpPresident · Also traded RCUS in the last 90 days